Events

Retiro De Equipo (Recall) de Immunochemical test reagent

Según Korean Food & Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en South Korea que fue producido por Korea Abbott Co., Ltd..

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    485
  • Fecha
    2016-03-30
  • País del evento
    South Korea
  • Fuente del evento
    KFDA
  • URL de la fuente del evento
    https://emed.mfds.go.kr
  • Notas / Alertas
    Korean data is current through September 2018. All of the data comes from Korean Food & Drug Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and South Korea.
  • Notas adicionales en la data
    No. 13-2045

Device

Immunochemical test reagent

Manufacturer

Korea Abbott Co., Ltd.
  • Dirección del fabricante
    Seoul 421, Yeongdongdao, Gangnam-gu, Seoul
  • Empresa matriz del fabricante (2017)
    Abbott Laboratories
  • Comentario del fabricante
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    KFDA